Valeant Pharmaceuticals And Metabasis Therapeutics License Rights To Hepatitis B Compound Pradefovir To Schering-Plough Corporation

Mon, 25 Dec 2006 02:00 PM EST

... Valeant Pharmaceuticals International (NYSE: VRX) and Metabasis Therapeutics, Inc. (Nasdaq: MBRX) today announced the signing of definitive agreements for the assignment and license of development and commercial rights to pradefovir to Schering-Plough Corporation (NYSE: SGP). [click link for full article] ...